Premium
Postmarketing surveillance: strengths and limitations. The flucloxacillin–dicloxacillin story
Author(s) -
Boyd Ian W
Publication year - 1999
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.1999.tb123611.x
Subject(s) - flucloxacillin , section (typography) , postmarketing surveillance , medicine , library science , computer science , pharmacology , adverse effect , advertising , business , biology , bacteria , genetics , staphylococcus aureus